LDS/Medical Tests/Spinocerebellar Ataxia Type 1 (ATXN1) Gene Mutation Analysis

Spinocerebellar Ataxia Type 1 (ATXN1) Gene Mutation Analysis

Spinocerebellar ataxia type 1 (SCA1) is an adult-onset autosomal dominant neurodegenerative disorder. SCA1 is associated with cerebellar ataxia, and shows pyramidal signs, variable degrees of neuropathy, movement disorders, oculomotor abnormalities, mild dysphagia and cognitive impairment.

The ATXN1 gene is located on chromosome 6p22 and encodes the ataxin 1 protein. SCA1 is caused by trinucleotide repeat expansion in the ATXN1. This mutation increases the length of the repeated CAG segment in the ATXN1 gene. Normally, the CAG segment is repeated 4 to 39 times within the gene. In people with SCA1, the CAG segment is repeated 40 to more than 80 times. Individual with 40 to 50 repeats tend to have symptoms of SCA1 in mid-adulthood, while people with more than 70 repeats usually have symptoms by their teens.

An increase in the length of the CAG segment leads to the production of an abnormally long version of the ataxin-1 protein that damages cells and leads to cell death. Abnormal ataxin-1 is found in the central nervous system. Therefore, the loss of the cells in the CNS causes the cognitive and movement problems characteristic of SCA1. SCA1 affects 1 to 2 per 100,000 people worldwide.

  • For the diagnosis of Spinocerebellar ataxia type 1
  • To identify carrier with a family history of SCA1

Normal alleles:

  • 6 to 35 CAG trinucleotide repeats

Mutable Normal Alleles:

  • 36 to 38 CAG trinucleotide repeats without CAT interruptions

Abnormal Alleles:

  • 39 to 44 CAG repeats without CAT interruptions and all alleles > 45 repeats

Normal: < 35 CAG trinucleotide repeats

Next generation sequencing, Bi-directional Sanger Sequence Analysis, repeat expansion detection by PCR, gel electrophoresis, Deletion/duplication analysis.

Whole blood (EDTA/Lavender top tube).

Stability

  • Room temperature: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: Unacceptable
Targeted variant analysis, Sequence analysis of select exons, Sequence analysis of the entire coding region, Deletion/duplication analysis, Microsatellite instability testing (MSI), Fragile X gene mutation analysis.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login